Lucid Diagnostics Shares Fall After Pricing of Public Stock Offering

Dow Jones

09/10

By Freddy Sebastian

Shares of Lucid Diagnostics fell after its secondary offering of common shares priced.

Its stock slid 17.3% to $1.05 in premarket trading on Wednesday.

The cancer-prevention medical diagnostics company said its underwritten public offering of 25 million shares was priced at $1 apiece.

Lucid also said it granted underwriters a 30-day option to purchase up to an additional 3.75 million common shares at the public offering price, excluding underwriting discounts and commissions.

The offering is expected to close on Thursday.

The company, which is a unit of PAVmed Inc., said it would use the gross proceeds of $25 million for working capital and general corporate purposes.

Write to Freddy Sebastian at freddy.sebastian@wsj.com

(END) Dow Jones Newswires

September 10, 2025 09:00 ET (13:00 GMT)

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2566601552"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2566601552\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2566601552?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-10 21:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2566601552","market":"us","top_or_hot":-1,"title":"Lucid Diagnostics Shares Fall After Pricing of Public Stock Offering","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Freddy Sebastian \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of <a href=\"https://laohu8.com/S/LUCD\">Lucid Diagnostics</a> fell after its secondary offering of common shares priced. \n</p>\n<p>\n  Its stock slid 17.3% to $1.05 in premarket trading on Wednesday. \n</p>\n<p>\n  The cancer-prevention medical diagnostics company said its underwritten public offering of 25 million shares was priced at $1 apiece. \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/LCID\">Lucid</a> also said it granted underwriters a 30-day option to purchase up to an additional 3.75 million common shares at the public offering price, excluding underwriting discounts and commissions. \n</p>\n<p>\n  The offering is expected to close on Thursday. \n</p>\n<p>\n  The company, which is a unit of <a href=\"https://laohu8.com/S/PAVM\">PAVmed Inc.</a>, said it would use the gross proceeds of $25 million for working capital and general corporate purposes. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Freddy Sebastian at freddy.sebastian@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  September 10, 2025 09:00 ET (13:00 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lucid Diagnostics Shares Fall After Pricing of Public Stock Offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLucid Diagnostics Shares Fall After Pricing of Public Stock Offering\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-09-10 21:00</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Freddy Sebastian \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of <a href=\"https://laohu8.com/S/LUCD\">Lucid Diagnostics</a> fell after its secondary offering of common shares priced. \n</p>\n<p>\n  Its stock slid 17.3% to $1.05 in premarket trading on Wednesday. \n</p>\n<p>\n  The cancer-prevention medical diagnostics company said its underwritten public offering of 25 million shares was priced at $1 apiece. \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/LCID\">Lucid</a> also said it granted underwriters a 30-day option to purchase up to an additional 3.75 million common shares at the public offering price, excluding underwriting discounts and commissions. \n</p>\n<p>\n  The offering is expected to close on Thursday. \n</p>\n<p>\n  The company, which is a unit of <a href=\"https://laohu8.com/S/PAVM\">PAVmed Inc.</a>, said it would use the gross proceeds of $25 million for working capital and general corporate purposes. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Freddy Sebastian at freddy.sebastian@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  September 10, 2025 09:00 ET (13:00 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"醫療保健設備","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2566601552","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2566601552","pubTimestamp":1757509200,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of Lucid Diagnostics fell after its secondary offering of common shares priced.Its stock slid 17.3% to $1.05 in premarket trading on Wednesday.The cancer-prevention medical diagnostics company said its underwritten public offering of 25 million shares was priced at $1 apiece.Lucid also said it granted underwriters a 30-day option to purchase up to an additional 3.75 million common shares at the public offering price, excluding underwriting discounts and commissions.The offering is expected to close on Thursday.The company, which is a unit of PAVmed Inc., said it would use the gross proceeds of $25 million for working capital and general corporate purposes.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","BK4555":"新能源车","LUCD":"LUCID DIAGNOSTICS INC.","BK4596":"哈里斯概念","BK4551":"寇图资本持仓","BK4099":"汽车制造商"},"translate_title":"Lucid Diagnostics股价在公开股票发行定价后下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LUCD":0.9},"content_text":"By Freddy Sebastian \n\n\n \n\n\n  Shares of Lucid Diagnostics fell after its secondary offering of common shares priced. \n\n\n  Its stock slid 17.3% to $1.05 in premarket trading on Wednesday. \n\n\n  The cancer-prevention medical diagnostics company said its underwritten public offering of 25 million shares was priced at $1 apiece. \n\n\nLucid also said it granted underwriters a 30-day option to purchase up to an additional 3.75 million common shares at the public offering price, excluding underwriting discounts and commissions. \n\n\n  The offering is expected to close on Thursday. \n\n\n  The company, which is a unit of PAVmed Inc., said it would use the gross proceeds of $25 million for working capital and general corporate purposes. \n\n\n \n\n\n  Write to Freddy Sebastian at freddy.sebastian@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 10, 2025 09:00 ET (13:00 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}